OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluations
Abeer A. Mohamed, Sanadelaslam S. A. El‐Hddad, Ahmed K. B. Aljohani, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107062-107062
Closed Access | Times Cited: 9
Abeer A. Mohamed, Sanadelaslam S. A. El‐Hddad, Ahmed K. B. Aljohani, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107062-107062
Closed Access | Times Cited: 9
Showing 9 citing articles:
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFRWT and EGFRT790M: design, synthesis, ADMET and molecular docking
Ahmed K. B. Aljohani, Khaled El‐Adl, Basmah Almohaywi, et al.
RSC Advances (2024) Vol. 14, Iss. 12, pp. 7964-7980
Open Access | Times Cited: 5
Ahmed K. B. Aljohani, Khaled El‐Adl, Basmah Almohaywi, et al.
RSC Advances (2024) Vol. 14, Iss. 12, pp. 7964-7980
Open Access | Times Cited: 5
Exploration of the VEGFR-2 inhibition activity of phthalazine derivatives: design, synthesis, cytotoxicity, ADMET, molecular docking and dynamic simulation
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
RSC Advances (2024) Vol. 14, Iss. 30, pp. 21668-21681
Open Access | Times Cited: 4
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
RSC Advances (2024) Vol. 14, Iss. 30, pp. 21668-21681
Open Access | Times Cited: 4
Discovery of 1-phenyl-1,2,3-triazole ureas as dual VEGFR-2/JNK-1 type II kinase inhibitors targeting pancreatic cancer
Wagdy M. Eldehna, Eslam Roshdy, Maha-Hamadien Abdulla, et al.
International Journal of Biological Macromolecules (2025), pp. 142372-142372
Closed Access
Wagdy M. Eldehna, Eslam Roshdy, Maha-Hamadien Abdulla, et al.
International Journal of Biological Macromolecules (2025), pp. 142372-142372
Closed Access
EGFR Inhibitors Across Generations: Progress, Challenges, and Future Directions
Vishal G. Deshmukh, Suryakant B. Sapkal, Suchita S. Gadekar, et al.
Journal of Molecular Structure (2025), pp. 142326-142326
Closed Access
Vishal G. Deshmukh, Suryakant B. Sapkal, Suchita S. Gadekar, et al.
Journal of Molecular Structure (2025), pp. 142326-142326
Closed Access
New benzimidazole‐oxadiazole derivatives as potent VEGFR‐2 inhibitors: Synthesis, anticancer evaluation, and docking study
Ulviye Acar Çevik, İsmail Çeli̇k, Şennur Görgülü, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Open Access | Times Cited: 3
Ulviye Acar Çevik, İsmail Çeli̇k, Şennur Görgülü, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Open Access | Times Cited: 3
Advances in Cancer Therapy: A Comprehensive Review of CDK and EGFR Inhibitors
Mohammed Hawash
Cells (2024) Vol. 13, Iss. 19, pp. 1656-1656
Open Access | Times Cited: 3
Mohammed Hawash
Cells (2024) Vol. 13, Iss. 19, pp. 1656-1656
Open Access | Times Cited: 3
Rationale, in silico docking, ADMET profile, design, synthesis and cytotoxicity evaluations of phthalazine derivatives as VEGFR-2 inhibitors and apoptosis inducers
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
RSC Advances (2024) Vol. 14, Iss. 37, pp. 27110-27121
Open Access | Times Cited: 2
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
RSC Advances (2024) Vol. 14, Iss. 37, pp. 27110-27121
Open Access | Times Cited: 2
Exploration of cytotoxicity of iodoquinazoline derivatives as inhibitors of both VEGFR‐2 and EGFRT790M: Molecular docking, ADMET, design, and syntheses
Marwa Alsulaimany, Sanadelaslam S. A. El‐Hddad, Zuhir S. M. Akrim, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Open Access | Times Cited: 1
Marwa Alsulaimany, Sanadelaslam S. A. El‐Hddad, Zuhir S. M. Akrim, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Open Access | Times Cited: 1
Phthalazine Derivatives as VEGFR‐2 Inhibitors: Docking, ADMET, Synthesis, Design, Anticancer Evaluations, and Apoptosis Inducers
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
Drug Development Research (2024) Vol. 86, Iss. 1
Closed Access
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
Drug Development Research (2024) Vol. 86, Iss. 1
Closed Access
